AZ Four Arrows Stone Medicine: MNC competes for early research in China
Reshaping Global Value Division
Time：
2026-07-04 08:18
Author：
xieyijun
AI pharmaceuticals, queuing for IPO
From financing competition to IPO competition.
Time：
2026-07-03 08:22
Author：
xieyijun
CPIC 2026 | Full schedule release, China's annual new drug benchmark has arrived
See you in Shanghai from July 22nd to 24th!
Time：
2026-07-02 08:26
Author：
写意君
How do multinational pharmaceutical companies view the future Chinese market?
Time：
2026-07-01 08:27
Author：
xieyijun
47 entrepreneurs give speeches on stage!
Time：
2026-06-30 08:12
Author：
xieyijun
Top Wall Street capital reevaluates China's innovative drugs
From the perspective of the Chief Investment Officer of RTW Investments
Time：
2026-06-29 08:20
Author：
xieyijun
Bloomberg: Blocking Chinese new drugs, who is the United States protecting?
China's pharmaceutical dominance has just begun.
Time：
2026-06-27 20:50
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务